Latest Development Approvals News

Page 3 of 15
White Energy has completed the A$0.5 million acquisition of the South Galilee Coal Project, taking control of the entities that hold its tenements. The transaction gives the company another coal asset, but the filing provides no development timetable, resource figures or production outlook.
Maxwell Dee
Maxwell Dee
13 Oct 2026
CVC Limited (ASX:CVC) ended FY26 with $87.7 million in cash after a major Laverton sale, debt refinancing and a decision to abandon a $124 million property settlement. The stronger liquidity position came alongside a 541.7% rise in underlying NPAT, although earnings remain dependent on lumpy property realisations and planning approvals.
Victor Sage
Victor Sage
9 Oct 2026
Eureka Group Holdings delivered FY26 underlying earnings ahead of guidance as its all-age rental portfolio expanded rapidly, but statutory profit fell and borrowings more than doubled. The next test is whether acquisitions, development and new capital partnerships can convert scale into durable cash returns.
Eva Park
Eva Park
30 Sept 2026
Ark Mines has reported a FY2026 profit after receiving Queensland-backed funding, while its Sandy Mitchell rare earths resource expanded to 379.4 million tonnes after year end. The project now has development approvals and commercial-grade testwork behind it, but no Ore Reserve or mining decision yet.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Parkway Corporate Limited (ASX:PWN) delivered a sharp revenue increase in FY26 and generated positive operating cash flow, but slipped into a statutory loss and flagged significant uncertainty around its ability to continue as a going concern. Key approvals for its Queensland brine project and a new $2 million mining contract offer commercial progress, while funding remains the central test.
Victor Sage
Victor Sage
30 Sept 2026
Desane Group Holdings reported a sharp FY26 profit decline as lower property revaluation gains and higher finance costs overwhelmed largely stable rental income. The ASX-listed property group enters FY27 with more cash, conservative gearing and two developments that now need to convert asset value into earnings.
Eva Park
Eva Park
29 Sept 2026
Argent BioPharma has secured exclusive commercialisation rights to selected Tollovir, Tollovid and NutraVir antiviral products in a worldwide deal excluding China. The agreement adds a new commercial pillar alongside CimetrA®, but does not itself grant pharmaceutical development rights or establish clinical efficacy.
Victor Sage
Victor Sage
29 Sept 2026
Australian Vanadium reported progress across its mine, electrolyte and battery businesses, but auditors highlighted material uncertainty over the company’s ability to continue as a going concern. The group held $17.9 million in cash at 30 June, yet expects to need additional funding within 12 months.
Victor Sage
Victor Sage
25 Sept 2026
Silver Mines has secured firm commitments for a $70 million placement, giving the company more funding to advance its Bowdens Silver Project through development approvals and engineering studies. The raise also supports royalty acquisitions, exploration and land access, although nearly 43% of the new shares still require shareholder approval.
Maxwell Dee
Maxwell Dee
23 Sept 2026
Delorean Corporation and Opal have completed the concept stage for a proposed anaerobic digestion facility at Opal’s Maryvale Mill in Victoria. The project could replace natural gas used by the mill’s rotary lime kiln, but still requires further engineering, commercial work and a final investment decision.
Victor Sage
Victor Sage
23 Sept 2026
Harmoney will continue buying back up to 5% of its issued shares while reaffirming FY27 cash NPAT guidance of $16 million or more. The lender also says potential acquisitions could be funded without an equity raising, although no transaction has been announced.
Claire Turing
Claire Turing
22 Sept 2026
Sky Metals has used FY2026 to move Tallebung from exploration toward development, combining more than 500 drill holes with strong ore-sorting results and progress into NSW’s environmental approval process. The advance came alongside a A$5.37 million loss and continuing reliance on equity funding.
Maxwell Dee
Maxwell Dee
17 Sept 2026

Browse the archive

Full archive